Skip to content

Comparison Efficacy of The 1450 nm diode laser with 450 nm blue laser and 1450 nm diode laser for acne vulgaris in Thai patient , A Prospective randomized double blind , split-face study

Comparison Efficacy of The 1450 nm diode laser with 450 nm blue laser and 1450 nm diode laser for acne vulgaris in Thai patient : A Prospective randomized double blind , split-face study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250211001
Enrollment
25
Registered
2025-02-11
Start date
2025-08-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to sever acne grade I-IV by Investigator global assessment acne, laser 1450nm , laser 450nm

Interventions

Laser treatment using a diode laser at 1450 nm in combination with a 450 nm laser, utilizing the dual regimen technique Stamp mode: fluence 5-6 J/cm2 on inflamed acne, followed by Toning mode with 4 p
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Laser 1450 nm with Laser 450nm,Laser 1450 nm alone

Sponsors

NEXT LEVEL ENTERPRISE CO., LTD
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Thai Male and female, aged over 18 years. 2.Skin color type according to Fitzpatrick skin type I-V. 3.Presence of acne with severity ranging from I-IV, as assessed by the Investigator Global Assessment (IGA). 4.Willingness to participate in the project

Exclusion criteria

Exclusion criteria: 1.No use of acne medications or cosmetic products containing AHA, BHA, Benzoyl Peroxide, 2.Retinoids, or Azelaic Acid within the past 6 weeks. 3.No use of acne medications, other than isotretinoin, within the past 6 weeks. 4.No use of isotretinoin within the past 3 months. 5.No acne treatments using lasers or light therapy within the past 6 weeks. 6.No acne treatments involving chemical exfoliation (e.g., acids) within the past 6 weeks. 7.Not pregnant or breastfeeding. 8.No history of significant cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Total acne count 1 month after each intervention, with a total of 3 sessions acne count by blind dermatologist count acne via picture from VISIA scan

Secondary

MeasureTime frame
porphyrin score 1 month after each intervention, with a total of 3 sessions porphyrin level via VISIA scan,redness 1 month after each intervention, with a total of 3 sessions redness score via VISIA scan,Sebum level 1 month after each intervention, with a total of 3 sessions Sebum level by sebumeter measre at highest point of zygoma,pore size 1 month after each intervention, with a total of 3 sessions pore size score via VISA scan

Countries

Thailand

Contacts

Public ContactPhakkhawit Soontornphong

Dhurakij Pundit University

pkw.stp@gmail.com0833300414

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026